LP-188 Glucocorticoids withdrawn in systemic lupus erythematosus patients with serologically active clinically quiescent state: a desirable goal

• Xiaofeng Zeng,
• Qian Wang,
• Jiuliang Zhao,
• Xinping Tian,
• Mengtao Li,
• Yufang Ding

Affiliations

Xiaofeng Zeng

Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China

Qian Wang

Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China

Jiuliang Zhao

Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), China

Xinping Tian

Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China

Mengtao Li

Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Yufang Ding

Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), China